SE0101327D0 - New crystalline forms - Google Patents

New crystalline forms

Info

Publication number
SE0101327D0
SE0101327D0 SE0101327A SE0101327A SE0101327D0 SE 0101327 D0 SE0101327 D0 SE 0101327D0 SE 0101327 A SE0101327 A SE 0101327A SE 0101327 A SE0101327 A SE 0101327A SE 0101327 D0 SE0101327 D0 SE 0101327D0
Authority
SE
Sweden
Prior art keywords
oxa
crystalline forms
ylüethylcarbamate
tert
butyl
Prior art date
Application number
SE0101327A
Other languages
English (en)
Swedish (sv)
Inventor
Neil Barnwell
Annika Bjoere
Lal Lashkar Singh Cheema
David Cladingboel
Karin Loevqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101327A priority Critical patent/SE0101327D0/xx
Publication of SE0101327D0 publication Critical patent/SE0101327D0/xx
Priority to TW091106493A priority patent/TWI237025B/zh
Priority to ARP020101189A priority patent/AR035452A1/es
Priority to PT02761972T priority patent/PT1389213E/pt
Priority to SK1257-2003A priority patent/SK12572003A3/sk
Priority to MXPA03009206A priority patent/MXPA03009206A/es
Priority to AT02761972T priority patent/ATE323095T1/de
Priority to PL02367179A priority patent/PL367179A1/pl
Priority to ES02761972T priority patent/ES2261721T3/es
Priority to US10/474,592 priority patent/US7217708B2/en
Priority to CA002443470A priority patent/CA2443470A1/en
Priority to HU0303487A priority patent/HUP0303487A3/hu
Priority to IL15825002A priority patent/IL158250A0/xx
Priority to JP2002581443A priority patent/JP2004525970A/ja
Priority to EEP200300504A priority patent/EE200300504A/xx
Priority to EP02761972A priority patent/EP1389213B1/en
Priority to NZ528560A priority patent/NZ528560A/en
Priority to CNB028116283A priority patent/CN1269823C/zh
Priority to SI200230325T priority patent/SI1389213T1/sl
Priority to BR0208829-0A priority patent/BR0208829A/pt
Priority to RU2003129231/04A priority patent/RU2286993C2/ru
Priority to KR10-2003-7013320A priority patent/KR20030087078A/ko
Priority to PCT/SE2002/000725 priority patent/WO2002083688A1/en
Priority to CZ20032760A priority patent/CZ20032760A3/cs
Priority to DE60210598T priority patent/DE60210598T2/de
Priority to EP05007851A priority patent/EP1550663A1/en
Priority to DK02761972T priority patent/DK1389213T3/da
Priority to UA2003098709A priority patent/UA74629C2/uk
Priority to ZA200307759A priority patent/ZA200307759B/en
Priority to IS6980A priority patent/IS6980A/is
Priority to NO20034527A priority patent/NO20034527L/no
Priority to HK04104077A priority patent/HK1061026A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE0101327A 2001-04-12 2001-04-12 New crystalline forms SE0101327D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
TW091106493A TWI237025B (en) 2001-04-12 2002-04-01 New crystalline forms of antiarrhythmic compounds
ARP020101189A AR035452A1 (es) 2001-04-12 2002-04-02 Sales farmaceuticamente aceptables de compuestos antiarritmicos, procedimiento para la preparación de estas sales, formulación farmaceutica y el uso de estos compuestos para la manufactura de medicamentos para el uso en la profilaxis o el tratamiento de una arritmia
DK02761972T DK1389213T3 (da) 2001-04-12 2002-04-12 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
EEP200300504A EE200300504A (et) 2001-04-12 2002-04-12 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
SI200230325T SI1389213T1 (sl) 2001-04-12 2002-04-12 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
MXPA03009206A MXPA03009206A (es) 2001-04-12 2002-04-12 FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.
AT02761972T ATE323095T1 (de) 2001-04-12 2002-04-12 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
PL02367179A PL367179A1 (pl) 2001-04-12 2002-04-12 Preparaty 3,7-diazabicyklo[3.3.1] jako związki przeciwarytmiczne
ES02761972T ES2261721T3 (es) 2001-04-12 2002-04-12 Formulaciones de 3,7-diazabiciclo(3.3.1) como compuestos antiarritmicos.
US10/474,592 US7217708B2 (en) 2001-04-12 2002-04-12 3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
CA002443470A CA2443470A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
HU0303487A HUP0303487A3 (en) 2001-04-12 2002-04-12 Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anthiarhythmic agents and process for preparation of the compounds
IL15825002A IL158250A0 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
JP2002581443A JP2004525970A (ja) 2001-04-12 2002-04-12 抗不整脈化合物としての３，７−ジアザビシクロ［３．３．１］製剤
PT02761972T PT1389213E (pt) 2001-04-12 2002-04-12 Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos
EP02761972A EP1389213B1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo 3.3.1| formulations as antiarhythmic compounds
NZ528560A NZ528560A (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
CNB028116283A CN1269823C (zh) 2001-04-12 2002-04-12 作为抗心律不齐化合物的3,7－二氮杂双环[3.3.1]制剂
SK1257-2003A SK12572003A3 (sk) 2001-04-12 2002-04-12 Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo [3.3.1]-deriváty ako účinnú zložku a jej použitie
BR0208829-0A BR0208829A (pt) 2001-04-12 2002-04-12 Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia
RU2003129231/04A RU2286993C2 (ru) 2001-04-12 2002-04-12 3,7-диазабицикло[3.3.1]-препараты как антиаритмические соединения
KR10-2003-7013320A KR20030087078A (ko) 2001-04-12 2002-04-12 항부정맥 화합물로서의 3,7-디아자비시클로[3.3.1] 조성물
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
CZ20032760A CZ20032760A3 (cs) 2001-04-12 2002-04-12 Farmaceutická kompozice obsahující 3,7-diazabicyklo[3.3.1]-deriváty jako účinnou složku a její použití
DE60210598T DE60210598T2 (de) 2001-04-12 2002-04-12 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
EP05007851A EP1550663A1 (en) 2001-04-12 2002-04-12 New crystalline forms of antiarrhythmic compounds
UA2003098709A UA74629C2 (en) 2001-04-12 2002-12-04 A derivative of 3,7-diazabicyclo [3,3,1] compounds , pharmaceutically acceptable salts thereof, a method for producing and composition based thereon as antiarrhythmic agents
ZA200307759A ZA200307759B (en) 2001-04-12 2003-10-03 3,7-diazabicyclo[3.3.1]formulations as antiarrhythmic compounds.
IS6980A IS6980A (is) 2001-04-12 2003-10-08 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
NO20034527A NO20034527L (no) 2001-04-12 2003-10-09 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
HK04104077A HK1061026A1 (en) 2001-04-12 2004-06-08 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms

Publications (1)

Publication Number Publication Date
SE0101327D0 true SE0101327D0 (sv) 2001-04-12

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms

Country Status (30)

Country Link
US (1) US7217708B2 (pl)
EP (2) EP1389213B1 (pl)
JP (1) JP2004525970A (pl)
KR (1) KR20030087078A (pl)
CN (1) CN1269823C (pl)
AR (1) AR035452A1 (pl)
AT (1) ATE323095T1 (pl)
BR (1) BR0208829A (pl)
CA (1) CA2443470A1 (pl)
CZ (1) CZ20032760A3 (pl)
DE (1) DE60210598T2 (pl)
DK (1) DK1389213T3 (pl)
EE (1) EE200300504A (pl)
ES (1) ES2261721T3 (pl)
HK (1) HK1061026A1 (pl)
HU (1) HUP0303487A3 (pl)
IL (1) IL158250A0 (pl)
IS (1) IS6980A (pl)
MX (1) MXPA03009206A (pl)
NO (1) NO20034527L (pl)
NZ (1) NZ528560A (pl)
PL (1) PL367179A1 (pl)
PT (1) PT1389213E (pl)
RU (1) RU2286993C2 (pl)
SE (1) SE0101327D0 (pl)
SK (1) SK12572003A3 (pl)
TW (1) TWI237025B (pl)
UA (1) UA74629C2 (pl)
WO (1) WO2002083688A1 (pl)
ZA (1) ZA200307759B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
WO2006135316A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
AR057363A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n,n'-disustituidas
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
JP2009529539A (ja) * 2006-03-07 2009-08-20 エンダセア， インコーポレイテッド 呼吸器障害を治療するための方法および組成物
EP3026044B8 (en) 2006-06-26 2018-12-19 Akebia Therapeutics, Inc. Prolyl hydroxylase inhibitors and methods of use
WO2012170439A1 (en) 2011-06-06 2012-12-13 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (pl) 2011-06-06 2018-03-17
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
WO2016118858A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
US7217708B2 (en) 2007-05-15
DE60210598T2 (de) 2007-02-08
EP1389213A1 (en) 2004-02-18
RU2003129231A (ru) 2005-04-10
NZ528560A (en) 2005-05-27
JP2004525970A (ja) 2004-08-26
TWI237025B (en) 2005-08-01
ZA200307759B (en) 2005-01-03
DE60210598D1 (de) 2006-05-24
UA74629C2 (en) 2006-01-16
HUP0303487A3 (en) 2005-04-28
CN1514837A (zh) 2004-07-21
EP1389213B1 (en) 2006-04-12
ES2261721T3 (es) 2006-11-16
ATE323095T1 (de) 2006-04-15
MXPA03009206A (es) 2004-01-29
SK12572003A3 (sk) 2004-07-07
PT1389213E (pt) 2006-07-31
EE200300504A (et) 2003-12-15
WO2002083688A1 (en) 2002-10-24
RU2286993C2 (ru) 2006-11-10
AR035452A1 (es) 2004-05-26
KR20030087078A (ko) 2003-11-12
HK1061026A1 (en) 2004-09-03
EP1550663A1 (en) 2005-07-06
CA2443470A1 (en) 2002-10-24
CZ20032760A3 (cs) 2004-01-14
US20040143000A1 (en) 2004-07-22
DK1389213T3 (da) 2006-07-10
IS6980A (is) 2003-10-08
PL367179A1 (pl) 2005-02-21
NO20034527L (no) 2003-12-10
IL158250A0 (en) 2004-05-12
CN1269823C (zh) 2006-08-16
BR0208829A (pt) 2004-03-09
NO20034527D0 (no) 2003-10-09
HUP0303487A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
SE0101327D0 (sv) New crystalline forms
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
SE0100902D0 (sv) Compounds
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
SE9904176D0 (sv) New use
DE60216233D1 (en) Carbolinderivate
SI1392642T1 (sl) Nove spojine kot protivnetna, imunomodulacijska in antiproliferativna sredstva
DK0527036T3 (da) 4-Benzoylisoxazolderivater og deres anvendelse som herbicider
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE494893T1 (de) Sulfonamide, sulfamate und sulfamide als gamma- secretase-hemmer
DE602004027490D1 (de) Indazol-, benzisoxazol- und benzisothiazol-kinaseinhibitoren
NO20043098L (no) Alfa-(N-sulfonamido) acetamidderivater som beta-amyloidinhibitorer
ATE302775T1 (de) Carbolinderivate
ATE481093T1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
BR0209149A (pt) Ftalazinonas
MXPA03009750A (es) Compuestos quimicos.
MXPA02012076A (es) Compuestos quimicos.
MXPA02012659A (es) Derivados de pirazindiona condensados.
DE60218633D1 (de) Inhibitoren von cruzipain und anderen cysteinproteasen
SE0400043D0 (sv) New compounds
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ATE302776T1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
AR030756A1 (es) Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
BR9813719A (pt) Agentes terapêuticos